Pharvaris

Pharvaris(PHVS)

Netherlands - Leiden
Biotechnology

Focus: Small Molecules

Pharvaris is a life sciences company focused on Small Molecules.

Funding Stage
PUBLIC
Open Jobs
2

Pipeline & Clinical Trials

Phase 2
Clinical Trials (1)
NCT04618211Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
Phase 2
Deucrictibant low dose
Hereditary Angioedema
Phase 2
Clinical Trials (1)
NCT05047185Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II
Phase 2
deucrictibant selected dose
Hereditary Angioedema
Phase 2/3
Clinical Trials (1)
NCT05396105Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
Phase 2/3
Phase 3
Clinical Trials (1)
NCT06679881Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE
Phase 3
Phase 3
Clinical Trials (1)
NCT06669754Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE
Phase 3
Deucrictibant, Placebo
Hereditary Angioedema
Phase 3
Clinical Trials (1)
NCT06343779Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema
Phase 3
Clinical Trials (1)
NCT07266805Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency
Phase 3
Clinical Trials (1)
NCT05834777Prevention of Intradialytic Hypotension by Inhibiting Bradykinin B2 Receptor
Phase 3

Open Jobs (2)

Interview Prep Quick Facts
Portfolio: 8 clinical trials
Open Roles: 2 active jobs

Hiring Trend

Stable
2
Open Roles
+1
Added
-1
Filled/Removed

Based on last 4 crawl cycles